[1] KAWASAKI T.Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children[J].Arerugi,1967,16(3):178-222.
[2] 江彦秋,黄先玫.川崎病的免疫与遗传学发病机制研究进展[J].中华实用儿科临床杂志,2017(9):717-720.
[3] NEWBURGER J W,TAKAHASHI M,GERBER M A,et al.Diagnosis,treatment,and long-term management of Kawasaki disease:a statement for health professionals from the committee on rheumatic fever,endocarditis,and kawasaki disease,council on cardiovascular disease in the young,American heart association[J].Pediatrics,2004,114(6):1708-1733.
[4] 高燕,赵璐,刘芳,等.川崎病合并冠状动脉病变[J].中国小儿急救医学,2014(6):393-395.
[5] LIANG C D,KUO H C,YANG K D,et al.Coronary artery fistula associated with Kawasaki disease[J].Am Heart J,2009,157(3):584-588.
[6] 徐雯雅,刘桂英.川崎病合并冠状动脉损害危险因素研究进展[J].中国医药,2016,11(2):293-297.
[7] 梁秋月,刘晓燕.川崎病冠状动脉血栓形成发病机制及治疗进展[J].国际儿科学杂志,2016,43(3):213-216.
[8] 朱丹颖.川崎病冠状动脉损害易患基因研究进展[J].国际儿科学杂志,2017,44(5):297-300.
[9] 赵峥山.川崎病冠状动脉病变的遗传学研究进展[J].国际儿科学杂志,2018,45(5):329-332.
[10] CAO H.Adipocytokines in obesity and metabolic disease[J].J Endocrinol,2014,220 (2):T47-T59.
[11] CARBONE F,MACH F,MONTECUCCOF.The role of adipocytokines in atherogenesis and atheroprogression[J].Curr Drug Targets,2015,16(4):295-320.
[12] OUCHI N,HIGUCHI A,OHASHI K,et al.Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity[J].Science,2010,329(5990):454-457.
[13] KEMMOTSU Y,SAJI T,KUSUNOKI N,et al.Serum adipokine profiles in Kawasaki disease[J].Mod Rheumatol,2012,22(1):66-72.
[14] KIM H J,CHOI E H,KIL H R.Association between adipokines and coronary artery lesions in children with Kawasaki Disease[J].J Korean Med Sci,2014,29(10):1385-1390.
[15] MCCRINDLE B W,ROWLEY A H,NEWBURGER J W,et al.Diagnosis,treatment,and long-term management of Kawasaki disease:A scientific statement for health professionals from the American heart association[J].Circulation,2017,135(17):e927-e999.
[16] 刘宁.川崎病的治疗进展[J].医药导报,2016,35(2):157-161.
[17] BOZAOGLU K,BOLTON K,McMILLAN J,et al.Chemerin is a novel adipokine associated with obesity and metabolic syndrome[J].Endocrinology,2007,148(10):4687-4694.
[18] ZABEL B A,ZUNIGA L,OHYAMA T,et al.Chemoattractants,extracellular proteases,and the integrated host defense response[J].Exp Hematol,2006,34(8):1021-1032.
[19] PAROLINI S,SANTORO A,MARCENARO E,et al.The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues[J].Blood,2007,109(9):3625-3632.
[20] LANDGRAF K,FRIEBE D,ULLRICH T,et al.Chemerin as a mediator between obesity and vascular inflammation in children[J].J Clin Endocrinol Metab,2012,97(4):E556-E564.
[21] GU P,JIANG W,LU B,et al.Chemerin is associated with inflammatory markers and metabolic syndrome phenotypes in hypertension patients[J].Clin Exp Hypertens,2014,36(5):326-332.
[22] ERDOGAN S,YILMAZ F M,YAZICI O,et al.Inflammation and chemerin in colorectal cancer[J].Tumour Biol,2016,37(5):6337-6342.
[23] DESSEIN P H,TSANG L,WOODIWISS A J,et al.Circulating concentrations of the novel adipokine chemerin are associated with cardiovascular disease risk in rheumatoid arthritis[J].J Rheumatol,2014,41(9):1746-1754.
[24] SENOLT L,POLANSKA M,FILKOVA M,et al.Vaspin and omentin:new adipokines differentially regulated at the site of inflammation in rheumatoid arthritis[J].Ann Rheum Dis,2010,69(7):1410-1411.
[25] MENZEL J,DI GIUSEPPE R,BIEMANN R,et al.Association between chemerin,omentin-1 and risk of heart failure in the population-based EPIC-Potsdam study[J].Sci Rep,2017,7(1):14171.
[26] OHASHI K,SHIBATA R,MUROHARA T,et al.Role of anti-inflammatory adipokines in obesity-related diseases[J].Trends Endocrinol Metab,2014,25(7):348-355.
[27] NIGRO E,SCUDIERO O,MONACO M L,et al.New insight into adiponectin role in obesity and obesity-related diseases[J].Biomed Res Int,2014,2014:658913.
[28] SHIBATA S,TADA Y,HAU C,et al.Adiponectin as an anti-inflammatory factor in the pathogenesis of psoriasis:induction of elevated serum adiponectin levels following therapy[J].Br J Dermatol,2011,164(3):667-670.
[29] LEE Y,SCHULTE D J,SHIMADA K,et al.Interleukin-1beta is crucial for the induction of coronary artery inflammation in a mouse model of Kawasaki disease[J].Circulation,2012,125(12):1542-1550. |